Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks

Charles P. Raines, Charles Flexner, Eugene Sun, Margo Heath-Chiozzi, Ronald H. Lewis, Cathy Fields, Carl Deetz, Linda Apuzzo, Susan H. Eshleman, J. Brooks Jackson, Joel E. Gallant

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks'. Together they form a unique fingerprint.

Medicine & Life Sciences